Literature DB >> 25566952

Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response.

Atsushi Ogura1, Akiko Chino, Tsuyoshi Konishi, Takashi Akiyoshi, Teruhito Kishihara, Yoshiro Tamegai, Masashi Ueno, Masahiro Igarashi.   

Abstract

PURPOSE: The management of rectal cancer is a significant oncologic challenge because rectal cancer has a poor prognosis among the various types of colorectal cancer. There have been several recent reports on a nonoperative approach for advanced lower rectal cancer, and this may be best for local disease control. However, objective evaluation of tumor response after preoperative chemoradiotherapy has not been standardized. The purpose of this study is to evaluate our method of endoscopic evaluation of complete response.
METHODS: This is a retrospective chart review. All patients received a long course of preoperative chemoradiotherapy (5-fluorouracil-based chemotherapy and 45-50.4 Gy) followed by radical surgical resection from May 2005 to March 2012 in The Cancer Institute Hospital of Japanese Foundation for Cancer Research. One hundred fifty-seven patients were reviewed consecutively. Criteria for endoscopic complete response were defined with a focus on the degree of ulcer healing and pit pattern without magnification.
RESULTS: Endoscopic CR (E-CR) evaluation with our definitions reflected histopathologic response evaluation with an accuracy of 91.7 %, sensitivity of 27.8 %, specificity of 100 %, positive predictive value (PPV) of 100 %, and negative predictive value (NPV) of 91.4 % (p < 0.001). Our criteria of E-CR led all cases of y-clinical CR (ycCR) to pathological CR.
CONCLUSIONS: Endoscopic evaluation focused on the degree of ulcer healing, and pit pattern without magnification is useful for judging ycCR.

Entities:  

Mesh:

Year:  2015        PMID: 25566952     DOI: 10.1007/s00384-014-2105-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  21 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?

Authors:  Angelita Habr-Gama; Jorge Sabbaga; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Patricia Bailão Aguilar; Wladimir Nadalin; Rodrigo O Perez
Journal:  Dis Colon Rectum       Date:  2013-10       Impact factor: 4.585

3.  [Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].

Authors:  Kohei Murata; Shu Okamura; Hirofumi Okubo; Yoshiyuki Owada; Takahiko Nishigaki; Yuma Wada; Ryo Kato; Shunichiro Makino; Tomohira Takeoka; Kazuyuki Okada; Nariaki Fukuchi; Chikara Ebisui; Masakatsu Kinuta
Journal:  Gan To Kagaku Ryoho       Date:  2013-11

4.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

5.  Prospective feasibility study to evaluate neoadjuvant-synchronous S-1 + RT for locally advanced rectal cancer: a multicenter phase II trial (UMIN ID: 03396).

Authors:  Masafumi Inomata; Tomonori Akagi; Kentaro Nakajima; Tsuyoshi Etoh; Norio Shiraishi; Koichiro Tahara; Toshifumi Matsumoto; Tadahiko Kinoshita; Kyuzo Fujii; Akio Shiromizu; Nobuhiro Kubo; Seigo Kitano
Journal:  Jpn J Clin Oncol       Date:  2012-12-28       Impact factor: 3.019

6.  Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Maki Fukasawa; Kenji Ishikawa; Akemi Kamijo; Seiei Yasuda; Hiroyasu Makuuchi; Yukio Ohizumi; Chieko Murayama
Journal:  Jpn J Clin Oncol       Date:  2004-12       Impact factor: 3.019

7.  Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.

Authors:  Matthew F Kalady; Luiz Felipe de Campos-Lobato; Luca Stocchi; Daniel P Geisler; David Dietz; Ian C Lavery; Victor W Fazio
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

8.  Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response.

Authors:  Jeong Hyun Kang; Young Chul Kim; Hyunki Kim; Young Wan Kim; Hyuk Hur; Jin Soo Kim; Byung Soh Min; Hogeun Kim; Joon Seok Lim; Jinsil Seong; Ki Chang Keum; Nam Kyu Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-03       Impact factor: 7.038

9.  [Neoadjuvant chemoradiotherapy for locally advanced rectal cancer].

Authors:  Yoshiaki Kuriu; Yukihito Kokuba; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Hisashi Ikoma; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Toshiya Ochiai; Eigo Otsuji
Journal:  Gan To Kagaku Ryoho       Date:  2012-11

10.  Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy?

Authors:  Oded Zmora; Giovanna M Dasilva; Brooke Gurland; Raphael Pfeffer; Moshe Koller; Juan J Nogueras; Steven D Wexner
Journal:  Dis Colon Rectum       Date:  2004-10       Impact factor: 4.585

View more
  4 in total

1.  Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer.

Authors:  Sun Gyo Lim; Young Bae Kim; Seung Yeop Oh
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

2.  Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.

Authors:  Min Soo Cho; HonSoul Kim; Yoon Dae Han; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Jae Hee Cheon; Joon Seok Lim; Kang Young Lee; Nam Kyu Kim
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer.

Authors:  Junbing Chen; Zhouqiao Wu; Xiaoyan Zhang; Zining Liu; Yiding Wang; Fei Shan; Yinkui Wang; Shaojun Xia; Yan Zhang; Yingshi Sun; Jiafu Ji; Ziyu Li
Journal:  Int J Colorectal Dis       Date:  2022-10-15       Impact factor: 2.796

Review 4.  Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and Survival.

Authors:  K E O'Sullivan; E T Hurley; J P Hurley
Journal:  Gastroenterol Res Pract       Date:  2015-07-13       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.